Page last updated: 2024-10-20

urea and Long QT Syndrome

urea has been researched along with Long QT Syndrome in 2 studies

pseudourea: clinical use; structure
isourea : A carboximidic acid that is the imidic acid tautomer of urea, H2NC(=NH)OH, and its hydrocarbyl derivatives.

Long QT Syndrome: A condition that is characterized by episodes of fainting (SYNCOPE) and varying degree of ventricular arrhythmia as indicated by the prolonged QT interval. The inherited forms are caused by mutation of genes encoding cardiac ion channel proteins. The two major forms are ROMANO-WARD SYNDROME and JERVELL-LANGE NIELSEN SYNDROME.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Milani, G1
Budriesi, R1
Tavazzani, E1
Cavalluzzi, MM1
Mattioli, LB1
Miniero, DV1
Delre, P1
Belviso, BD1
Denegri, M1
Cuocci, C1
Rotondo, NP1
De Palma, A1
Gualdani, R1
Caliandro, R1
Mangiatordi, GF1
Kumawat, A1
Camilloni, C1
Priori, S1
Lentini, G1
Matsura, M1
Fujiwara, Y1
Ito, H1
Kandatsu, N1
Kato, N1
Harada, J1
Komatsu, T1

Trials

1 trial available for urea and Long QT Syndrome

ArticleYear
Prolongation of QT interval induced by electroconvulsive therapy is attenuated by landiolol.
    The journal of ECT, 2010, Volume: 26, Issue:1

    Topics: Adrenergic beta-Antagonists; Adult; Aged; Anesthesia, Intravenous; Anesthetics, Intravenous; Anti-Ar

2010

Other Studies

1 other study available for urea and Long QT Syndrome

ArticleYear
hERG stereoselective modulation by mexiletine-derived ureas: Molecular docking study, synthesis, and biological evaluation.
    Archiv der Pharmazie, 2023, Volume: 356, Issue:10

    Topics: Animals; Guinea Pigs; Humans; Long QT Syndrome; Mexiletine; Molecular Docking Simulation; Potassium

2023